Post-approval studies (Phase 4)Study completedNCT00230217
What this trial is testing
Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy
Who this might be right for
TumorsHyperuricemiaTumor Lysis Syndrome
Sanofi 94